Patents by Inventor Jin Mi Oh
Jin Mi Oh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240152225Abstract: A display device includes a first substrate; a second substrate facing the first substrate; a plurality of first electrodes and a plurality of second electrodes disposed between the first substrate and the second substrate; a third electrode on an outer side of the first substrate or the second substrate, the third electrode including an organic material and a carbon nano-tube; a plurality of first conductive lines extending along a first direction; a plurality of second conductive lines extending along the first direction; a plurality of third conductive lines extending along a second direction; and a thin film transistor including a semiconductor layer, a gate electrode, a source electrode, and a drain electrode. A sheet resistance of the third electrode may be greater than a sheet resistance of each of the plurality of first electrodes and a sheet resistance of each of the plurality of second electrodes.Type: ApplicationFiled: January 16, 2024Publication date: May 9, 2024Applicant: LG Display Co., Ltd.Inventors: Kum-Mi OH, Jin-Wuk KIM, Sung-Hee KIM
-
Patent number: 11931000Abstract: The present disclosure relates to an openable/closable vertebral endoscopic device. The openable/closable vertebral endoscopic device includes an endoscope body including a working channel for providing an access route of a surgical instrument to a diseased area of a human body, the working channel having an open channel formed by opening a portion of the working channel such that a portion of the surgical instrument inserted into the working channel is exposed to the outside; and a cover member provided on the endoscope body to selectively open or close the open channel of the endoscope body.Type: GrantFiled: October 10, 2018Date of Patent: March 19, 2024Assignees: THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION, S-MEDION CO., LTD.Inventors: Jin Sung Kim, Ji Woon Chun, Hyang Mi Oh
-
Patent number: 9322755Abstract: A cell capturing filter, in which cells or particles having a predetermined size or greater in a sample may be easily captured, and clogging of a flow passage due to the captured cells or particles may be prevented, and stresses acting on the captured cells or particles may be reduced, having a first surface and a second substrate having a second surface that is bonded to the first surface, wherein the first substrate may include a flow passage formed in the first surface of the first substrate so that a sample flows in the flow passage, and a barrier that protrudes across the flow passage, and the second substrate may include a fine groove formed in an area on the second surface corresponding to the barrier, and a gap may exist between a surface of the barrier and the fine groove.Type: GrantFiled: December 13, 2012Date of Patent: April 26, 2016Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Tae-seok Sim, Min-seoks Kim, Mi-jeong Song, Jeong-gun Lee, June-young Lee, Yeon-jeong Kim, Sang-hyun Baek, Jin-mi Oh, Hyo-young Jeong
-
Publication number: 20150093760Abstract: A cartridge for measuring a concentration of a glycated protein in a wide measurement range, a system for measuring a glycated protein, and a method of measuring a glycated protein using same.Type: ApplicationFiled: October 1, 2014Publication date: April 2, 2015Inventors: Sang-kyu Kim, Kyung-mi Song, Jin-mi Oh, Youn-suk Choi
-
Patent number: 8916525Abstract: The present invention relates to TNFR2-TWEAKR fusion protein, more precisely to TNFR2-TWEAKR fusion protein acting as a double-antagonist to TNF-? and TWEAK, known as major causes of autoimmune arthritis which is one of autoimmune diseases. When the composition comprising TNFR2-TWEAKR fusion protein was treated to Th17 cells, the secretion of the inflammatory cytokine IL-17 was reduced but the secretion of the anti-inflammatory cytokine IL-10 generated in Treg cells was increased. Such effect of TNFR2-TWEAKR fusion protein was far greater than that of a single protein such as TNFR2-Fc or TWEAK-Fc. The TNFR2-TWEAKR fusion protein of the present invention has not only excellent treatment effect on arthritis in CIA mouse model not also excellent treatment effect on autoimmune rheumatoid arthritis by increasing the expression of Treg, the immune suppressive cells.Type: GrantFiled: March 18, 2011Date of Patent: December 23, 2014Assignees: Korea Research Institute of Bioscience and Biotechnology, Industry-Academic Cooperation Foundation, The Catholic University of KoreaInventors: Young Woo Park, Ki Won Jo, Srok Ho Yoo, Jung Yu, Dong Jin Kim, Sun-Ha Yoon, Eun Jung Song, Eun Kyung Lee, Jin Mi Oh, Kyu Won Cho, Mi La Cho, Ho Youn Kim, Mi Kyung Park, Hye Jwa Oh, Jin Sil Park, Yun Ju Woo, Jae Kyeong Byun, Jun Geol Ryu
-
Publication number: 20140219869Abstract: Provided is a support for effectively capturing glycated protein in a sample, and a device and method for measuring the glycated protein by using the support.Type: ApplicationFiled: February 7, 2014Publication date: August 7, 2014Applicant: Samsung Electronics Co., Ltd.Inventors: Woochang LEE, Sang-kyu Kim, Kyung-mi Song, Jin-mi Oh, Soo-suk Lee, Youn-suk Choi
-
Patent number: 8753870Abstract: A device, system, and method for detecting or separating target molecules allowing efficient detection even when only a small amount of target molecules or target cells are included in a sample involving the use of a target molecule linkage portion, a signal production portion, and first and second separation portions.Type: GrantFiled: September 6, 2012Date of Patent: June 17, 2014Assignees: Samsung Electronics Co., Ltd., Industry -University Coorperation Foundation Sogang UniversityInventors: Hun-joo Lee, Jeong-gun Lee, Jeong-woo Choi, Yeon-jeong Kim, Jong-myeon Park, Mi-jeong Song, Jin-mi Oh
-
Publication number: 20140134717Abstract: A fluid treatment apparatus and method. The fluid treatment apparatus includes a chamber containing a first fluid with a first density and a second fluid with a second density, a channel disposed in the chamber to discharge the first fluid from the chamber, and a valve material disposed in the channel, wherein the valve material controls the discharge of the first fluid from the chamber based upon a phase transition characteristic.Type: ApplicationFiled: August 20, 2013Publication date: May 15, 2014Inventors: Hui-sung MOON, Tae-seok SIM, Jeong-gun LEE, Hyo-young JEONG, June-young LEE, Jin-mi OH
-
Publication number: 20140011192Abstract: A particle complex comprising a particle; a cleavable linker bound to a surface of the particle; and a macromolecule bound to the cleavable linker, wherein the macromolecule specifically binds to a surface marker of a target cell, and a method of isolating a target cell comprising same.Type: ApplicationFiled: February 22, 2013Publication date: January 9, 2014Applicant: SAMSUNG ELECTRONICS CO., LTD.Inventors: Hun-joo LEE, Jin-mi OH, Soo-suk LEE, Jeong-gun LEE
-
Publication number: 20130264295Abstract: A target material capturing filter is described herein. The target material capturing filter may include an inlet through which a fluid enters; an outlet through which at least a portion of the fluid is discharged; a first flow path that is connected to the inlet; a second flow path that is connected to the outlet; and a filter unit that is disposed between the first flow path and the second flow path and captures the target material by letting drop at least a portion of the fluid that flows through the first flow path.Type: ApplicationFiled: January 9, 2013Publication date: October 10, 2013Applicant: SAMSUNG ELECTRONICS CO., LTD.Inventors: June-young LEE, Hui-sung MOON, Min-seoks KIM, Yeon-jeong KIM, Sang-hyun BAEK, Tae-seok SIM, Jin-mi OH, Jeong-gun LEE, Hun-joo LEE, Hyo-young JEONG
-
Publication number: 20130178543Abstract: A method of detecting a cancer stem cell or circulating tumor cell that has undergone epithelial-mesenchymal transition, comprising determining the level of caveolin-1 expressed by a sample cell, and comparing the level of caveolin-1 expressed by the sample cell to a control, wherein higher expression of caveolin-1 by the sample cell indicates that the sample cell is a cancer cell, as well as a method of detecting cancer or metastasis in a subject, and related methods and compositions.Type: ApplicationFiled: August 24, 2012Publication date: July 11, 2013Applicants: AJOU UNIVERSITY INDUSTRY COOPERATION FOUNDATION, SAMSUNG ELECTRONICS CO., LTD.Inventors: Yeon-jeong KIM, You-sun KIM, Jeong-gun LEE, Sang-hyun BAEK, Jin-mi OH, Hyo-young JEONG
-
Publication number: 20130149774Abstract: A cell counter system includes an inlet via which a fluid containing a plurality of cells inflows; a channel in which the fluid flows; a valve unit, which controls flow of the fluid in the channel; an electrode unit, which is arranged in the channel for measuring impedance for counting a number of the plurality of cells; and an outlet, which is connected to the channel to drain the fluid.Type: ApplicationFiled: September 13, 2012Publication date: June 13, 2013Applicant: SAMSUNG ELECTRONICS CO., LTD.Inventors: Min-seok KIM, Tae-seok SIM, Yeon-jeong KIM, Sang-hyun BAEK, Jin-mi OH, Hyo-young JEONG, Jeong-gun LEE
-
Publication number: 20130137092Abstract: A device, system, and method for detecting or separating target molecules allowing efficient detection even when only a small amount of target molecules or target cells are included in a sample involving the use of a target molecule linkage portion, a signal production portion, and first and second separation portions.Type: ApplicationFiled: September 6, 2012Publication date: May 30, 2013Applicants: INDUSTRY-UNIVERSITY COOPERATION SOGANG UNIVERSITY, SAMSUNG ELECTRONICS CO., LTD.Inventors: Hun-joo LEE, Jeong-gun LEE, Jeong-woo CHOI, Yeon-jeong KIM, Jong-myeon PARK, Mi-jeong SONG, Jin-mi OH
-
Publication number: 20130017226Abstract: The present invention relates to TNFR2-TWEAKR fusion protein, more precisely to TNFR2-TWEAKR fusion protein acting as a double-antagonist to TNF-? and TWEAK, known as major causes of autoimmune arthritis which is one of autoimmune diseases. When the composition comprising TNFR2-TWEAKR fusion protein was treated to Th17 cells, the secretion of the inflammatory cytokine IL-17 was reduced but the secretion of the anti-inflammatory cytokine IL-10 generated in Treg cells was increased. Such effect of TNFR2-TWEAKR fusion protein was far greater than that of a single protein such as TNFR2-Fc or TWEAK-Fc. The TNFR2-TWEAKR fusion protein of the present invention has not only excellent treatment effect on arthritis in CIA mouse model not also excellent treatment effect on autoimmune rheumatoid arthritis by increasing the expression of Treg, the immune suppressive cells.Type: ApplicationFiled: March 18, 2011Publication date: January 17, 2013Applicants: Industry-Academic Cooperation Foundation, The Catholic University of Korea, Korea Research Institute of Bioscience and BiotechnologyInventors: Young Woo Park, Ki Won Jo, Srok Ho Yoo, Jung Yu, Dong Ji Kim, Sun-Ha Yoon, Eun Jung Song, Eun Kyung Lee, Jin Mi Oh, Kyu Won Cho, Mi La Cho, Ho Youn Kim, Mi Kyung Park, Hye Jwa Oh, Jin Sil Park, Yun Ju Woo, Jae Kyeong Byun, Jun Geol Ryu